[Monoclonal antibodies worldwide and for all?]

Med Sci (Paris). 2019 Dec;35(12):1196-1197. doi: 10.1051/medsci/2019213. Epub 2020 Jan 6.
[Article in French]
No abstract available

Publication types

  • Review

MeSH terms

  • Africa / epidemiology
  • Animals
  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal / therapeutic use*
  • Asia / epidemiology
  • Biosimilar Pharmaceuticals / economics
  • Biosimilar Pharmaceuticals / therapeutic use
  • Developed Countries / economics
  • Developed Countries / statistics & numerical data
  • Developing Countries / economics
  • Developing Countries / statistics & numerical data
  • Epidemics / economics
  • Epidemics / prevention & control
  • Geography
  • Global Health / economics
  • Global Health / statistics & numerical data
  • Global Health / trends
  • Health Services Accessibility* / economics
  • Health Services Accessibility* / organization & administration
  • Health Services Accessibility* / statistics & numerical data
  • Health Services Accessibility* / trends
  • Humans
  • Immunotherapy* / economics
  • Immunotherapy* / statistics & numerical data
  • Immunotherapy* / trends
  • South America / epidemiology
  • World Health Organization / economics

Substances

  • Antibodies, Monoclonal
  • Biosimilar Pharmaceuticals